Saphena Medical has raised $2.1 million in a new round of equity financing, according to an SEC filing posted this week. A total of 17 unnamed investors joined the round, with the date of the first sale recorded as June 12, 2018, according to the filing. The company offered Series D preferred stock in the […]
Saphena Medical said raised $2.7 million in a new round of equity financing, according to an SEC filing posted today. The company offered Series C preferred stock during the round, according to the SEC filing, with the 1st sale recorded on May 17. A total of 38 unnamed investors have joined the round, with Saphena looking to […]
Saphena Medical said today that late last month that it, and Dr. Albert Chin, filed counterclaims against Getinge‘s (PINK:GETI B) medical subsidiary Maquet Cardiovascular in response to a suit alleging patent infringement and breaches of contract. The counterclaim, filed on Feb. 22, is in response to an ongoing spat between the companies related to patents and intellectual […]
Getinge‘s (PINK:GETI B) medical subsidiary Maquet Cardiovascular said today it expanded a patent infringement suit against Saphena Medical and former employee Dr. Albert Chin, adding 2 specific actions taken by the defendants to the case. The amended complaint, originally filed on Dec. 16 in the United States District Court for the Northern District of California, addresses the application for […]
Getinge‘s (PINK:GETI B) medical subsidiary Maquet Cardiovascular said it filed a lawsuit this week against Saphena Medical and former employee Dr. Albert Chin, asserting that both parties infringed upon patents related to its VasoView endoscopic vein harvesting products. The suit, filed in the US District Court for the Northern District of California, asserts Dr. Chin took […]
Pavmed last week dramatically trimmed its pending initial public offering, saying it plans to float 1.2 million shares at $5 apiece for gross proceeds of $6 million. That’s a far cry from the $23 million top end Pavmed listed when it registered the IPO last May. Pavmed is developing devices in 5 areas, according to its […]
Stealthy Saphena Medical reported raising close to half of a $3 million planned offering toward development of a device designed to harvest veins for coronary artery bypass grafting.
The West Bridgewater, Mass.-based startup disclosed in a recent SEC filing that it has pulled in nearly $1.27 million so far, through the sale of Series B preferred stock.